IVOS Medical Logo teal

IVOS Medical Announces BOSS G4™ Video Laryngoscope Sheath Designed to Improve Intubation Safety in High-Risk Patients

Jan 22, 2025 | Press Release

Innovative Device Provides Clear Vision, Maintains Continuous Oxygen Delivery, and Clears Aspirate and Debris During Intubation

Irvine, CA – January 22, 2025, – IVOS Medical, Inc., a startup medical device company specializing in airway management, today announced the development of its BOSS G4™, an economical, single-use video laryngoscope sheath designed to enhance intubation safety, particularly for high-risk patients in emergency or soiled intubations. The BOSS G4 is compatible with existing video laryngoscope platforms and incorporates novel features to help maintain clear vision and provide continual oxygen delivery during intubation. IVOS Medical is initiating commercialization for the BOSS G4 and continuing product refinements, targeting market entry in 2026.

“Our BOSS G4 is designed to empower healthcare providers and first responders, and to raise the standard of care in intubation by improving outcomes in emergency intubation situations,” said Gabriel Punsalan, CRNA, MS, CEO and Co-founder of IVOS Medical.

About the IVOS BOSS G4™

The integrated IVOS BOSS (Breathing Optimization and Suction System) enables continuous suction by accommodating various suction methods, effectively clearing aspirate and debris from the oral cavity and trachea. Additionally, the sheath offers independent oxygen delivery, ensuring a clear tracheal view for precise tube placement and improved first-pass success rates. By minimizing the time patients go without oxygen, it improves both the safety and success rates of critical interventions—particularly vital in emergency, perioperative, and intensive care settings, where achieving first-pass intubation success is paramount.

About IVOS Medical
IVOS Medical is a medical device company committed to advancing airway management technology, particularly for challenging intubations. Its flagship product, the patent-pending Breathing Optimization and Suction System (BOSS™) G4™, enhances critical intubation success through video laryngoscopy. Founded by clinicians with extensive experience in airway management, the company addresses the significant challenges health care providers face during critical and emergency intubations. Supported by over $2 million in non-dilutive NIH SBIR funding and exclusively licensed from UC Irvine, IVOS Medical remains focused on elevating patient safety and healthcare efficiency through better intubation tools. For more information, visit www.ivosmedical.com or email info@ivosmedical.com.

###

The IVOS BOSS G4 is a trademark of IVOS MEDICAL, Inc. All other product or service names are the property of their respective owners.

Obstructed Vision in Soiled Airways

0-11 sec:

The initial insertion of the video laryngoscope resulted in obstruction of the camera view due to fluids in the oral cavity. The device was removed from the mouth, and the lens was manually cleaned to restore the camera to baseline functionality before being reinserted.

12-21 sec:

Once the video laryngoscope was reinserted into the oral cavity, critical time had already been lost, as the simulated patient remained apneic and gastric fluids continued to enter the lungs.

22-30 sec:

A Cormack-Lehane grade 1 view was achieved after aggressive suctioning with a Yankauer suction catheter. This provided clear visualization for the healthcare provider to insert the endotracheal tube using indirect visualization.

Obstructed Vision in Soiled Airways

0-13 sec:

The video laryngoscope is equipped with the IVOS BOSS G4™ system. The device integrates gas flow into the handle to continuously provide a clear camera window throughout the entire intubation process, without requiring removal of the device from the patient’s mouth.

14-27 sec:

The G4’s integrated suction channel removes oral cavity fluids and reduces the potential for aspirate to enter the lungs. Maintaining a clear view of the airway in an emergency setting can increase first-pass success, thereby reducing morbidity and mortality in patients.

28-37 sec:

The patient remains apneic for only a minimal amount of time while the healthcare provider inserts the endotracheal tube into the trachea and secures the airway for lifesaving ventilation.